• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Abnormal concentration of porphyrins in serum from COVID-19 patients.

作者信息

San Juan Itxaso, Bruzzone Chiara, Bizkarguenaga Maider, Bernardo-Seisdedos Ganeko, Laín Ana, Gil-Redondo Rubén, Diercks Tammo, Gil-Martínez Jon, Urquiza Pedro, Arana Eunate, Seco Marisa, García de Vicuña Aitor, Embade Nieves, Mato José M, Millet Oscar

机构信息

Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Derio, Spain.

ATLAS Molecular Pharma S. L, Derio, Spain.

出版信息

Br J Haematol. 2020 Sep;190(5):e265-e267. doi: 10.1111/bjh.17060. Epub 2020 Aug 29.

DOI:10.1111/bjh.17060
PMID:32745239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7436216/
Abstract
摘要

相似文献

1
Abnormal concentration of porphyrins in serum from COVID-19 patients.新型冠状病毒肺炎患者血清中卟啉浓度异常。
Br J Haematol. 2020 Sep;190(5):e265-e267. doi: 10.1111/bjh.17060. Epub 2020 Aug 29.
2
Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.2019年冠状病毒病（COVID-19）重症患者的凝血变化：一项荟萃分析。
Br J Haematol. 2020 Jun;189(6):1050-1052. doi: 10.1111/bjh.16725. Epub 2020 May 14.
3
Management of COVID-19-related paediatric blood samples in a clinical haematology laboratory.临床血液学实验室中与新冠病毒病相关的儿科血液样本管理
Br J Haematol. 2020 Jun;189(5):848-851. doi: 10.1111/bjh.16721. Epub 2020 May 9.
4
The association between COVID-19 and asthma: A systematic review and meta-analysis.2019冠状病毒病与哮喘之间的关联：一项系统评价和荟萃分析。
Clin Exp Allergy. 2020 Nov;50(11):1274-1277. doi: 10.1111/cea.13733. Epub 2020 Sep 24.
5
Thrombolysis restores perfusion in COVID-19 hypoxia.溶栓治疗可恢复新冠肺炎低氧血症患者的灌注。
Br J Haematol. 2020 Sep;190(5):e270-e274. doi: 10.1111/bjh.17050. Epub 2020 Aug 17.
6
Type I IFN immunoprofiling in COVID-19 patients.新冠病毒感染患者的I型干扰素免疫谱分析
J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29.
7
The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis.低血清白蛋白水平与重症新型冠状病毒肺炎的关联：一项系统综述和荟萃分析。
Crit Care. 2020 May 26;24(1):255. doi: 10.1186/s13054-020-02995-3.
8
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.新冠病毒肺炎患者的狼疮抗凝物与异常凝血检测
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
9
Kinetics of viral load and antibody response in relation to COVID-19 severity.病毒载量和抗体反应动力学与 COVID-19 严重程度的关系。
J Clin Invest. 2020 Oct 1;130(10):5235-5244. doi: 10.1172/JCI138759.
10
SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.SARS-CoV-2 半胱氨酸蛋白酶抗体可在 COVID-19 血清阳性个体的血清和唾液中检测到。
J Immunol. 2020 Dec 1;205(11):3130-3140. doi: 10.4049/jimmunol.2000842. Epub 2020 Nov 4.

引用本文的文献

1
Plasma metabolomics signatures predict COVID-19 patient outcome at ICU admission comparable to clinical scores.血浆代谢组学特征在重症监护病房（ICU）入院时可预测新冠病毒疾病（COVID-19）患者的预后，其预测能力与临床评分相当。
Sci Rep. 2025 May 3;15(1):15498. doi: 10.1038/s41598-025-00373-z.
2
Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome.一名患有新型冠状病毒肺炎相关的后部可逆性脑病综合征患者的未掩盖型急性间歇性卟啉病。
BMC Neurol. 2025 Apr 4;25(1):139. doi: 10.1186/s12883-025-04159-8.
3
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders.

本文引用的文献

1
H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer.基于 1H-NMR 的尿液代谢组学揭示前列腺癌中增强的碳氮循环迹象。
J Proteome Res. 2020 Jun 5;19(6):2419-2428. doi: 10.1021/acs.jproteome.0c00091. Epub 2020 May 18.
2
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
3
Hematological findings and complications of COVID-19.
肺部疾病进展过程中活性氧-炎症基因表达轴之间的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):417-448. doi: 10.1007/s00210-024-03392-1. Epub 2024 Aug 28.
4
Re: Porphyria Cutanea Tarda in a Patient with Myelofibrosis.关于：骨髓纤维化患者的迟发性皮肤卟啉症
Sultan Qaboos Univ Med J. 2023 Aug;23(3):425-426. doi: 10.18295/squmj.8.2023.047. Epub 2023 Aug 28.
5
Acute Intermittent Porphyria Attack Triggered by COVID-19 Infection.新冠病毒感染引发的急性间歇性卟啉病发作
Cureus. 2023 Apr 10;15(4):e37412. doi: 10.7759/cureus.37412. eCollection 2023 Apr.
6
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19.代谢组学作为COVID-19诊断、预后和药物干预分析的有力工具。
Front Mol Biosci. 2023 Feb 15;10:1111482. doi: 10.3389/fmolb.2023.1111482. eCollection 2023.
7
An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study.一种基于核磁共振的模型，用于在一项纵向研究中调查新冠肺炎患者的代谢表型逆转情况。
Metabolites. 2022 Dec 1;12(12):1206. doi: 10.3390/metabo12121206.
8
Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project.精准医学中的前瞻性代谢组学研究：AKRIBEA项目。
Handb Exp Pharmacol. 2023;277:275-297. doi: 10.1007/164_2022_610.
9
Association of COVID-19 with hepatic metabolic dysfunction.新型冠状病毒肺炎与肝脏代谢功能障碍的关联。
World J Virol. 2022 Sep 25;11(5):237-251. doi: 10.5501/wjv.v11.i5.237.
10
Host and viral proteins involved in SARS-CoV-2 infection differentially bind heme.宿主和病毒蛋白参与 SARS-CoV-2 感染并与血红素结合。
Protein Sci. 2022 Nov;31(11):e4451. doi: 10.1002/pro.4451.
COVID-19 的血液学表现及并发症。
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
4
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
5
Feasibility of cellular bioenergetics as a biomarker in porphyria patients.细胞生物能量学作为卟啉症患者生物标志物的可行性。
Mol Genet Metab Rep. 2019 Jan 29;19:100451. doi: 10.1016/j.ymgmr.2019.100451. eCollection 2019 Jun.
6
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.将环吡酮胺重新用作先天性红细胞生成性卟啉症模型中的药理学伴侣。
Sci Transl Med. 2018 Sep 19;10(459). doi: 10.1126/scitranslmed.aat7467.
7
Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.红细胞膜缺陷和地中海贫血特征中铁代谢与红细胞生成的特征分析。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):231-7. doi: 10.5507/bp.2015.054. Epub 2015 Oct 27.
8
Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease.红细胞群体动力学的调节是对疾病的一种基本稳态反应。
Am J Hematol. 2015 May;90(5):422-8. doi: 10.1002/ajh.23982. Epub 2015 Apr 2.
9
Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.蛋白酶体抑制剂在先天性红细胞生成性卟啉病中的治疗潜力。
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18238-43. doi: 10.1073/pnas.1314177110. Epub 2013 Oct 21.
10
The porphyrias: advances in diagnosis and treatment.卟啉症：诊断和治疗的进展。
Blood. 2012 Nov 29;120(23):4496-504. doi: 10.1182/blood-2012-05-423186. Epub 2012 Jul 12.